The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Open accessAbstract
Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the identified genomic alterations (GAs) in PDAC, oncogenic KRAS mutations are the most common, occurring in close to 90% of patients, followed by TP53, CDKN2A, and SMAD47,8.”
From Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma (2024) · cites this paper as [7]
In the citing paper
“Amongst these are four canonical mutations – KRAS (~85%), TP53 (60–70%), CDKN2A (>50%), and SMAD4 (~50%).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationMermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Self-citationNeoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,395
Self-citationThe patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Self-citationExome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P. S., Raine, K. M., Huang, D., Ong, C. K., Stephens, P., Davies, H. R., Jones, D., Lin, M., Teague, J. W., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,302
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,002
Takano, S., Fukasawa, M., Maekawa, S., Kadokura, M., Miura, M., Shindo, H., Takahashi, E., Sato, T., & Enomoto, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098718 · Cited by 64
Primary Urethral Clear-Cell Adenocarcinoma
Mehra, R., Vats, P., Sundaram, S. K., Udager, A. M., Roh, M. H., Alva, A. S., Pan, J., Lonigro, R. J., Siddiqui, J., Weizer, A. Z., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.023 · Cited by 64
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
Pinho, A. V., Bulck, M. V., Chantrill, L. A., Arshi, M., Sklyarova, T., Herrmann, D., Vennin, C., Gallego‐Ortega, D., Mawson, A., Giry-Laterrière, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07497-z · Cited by 66
Self-citationNeoplasms of the Exocrine Pancreas
Wolff, R. A., Crane, C. H., Li, D., Evans, D. B., Maitra, A., & Tsai, S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094 · Cited by 64
Self-citationInterplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 74
Barceló, C., Etchin, J., Mansour, M. R., Sanda, T., Morell, M., Lobo, V. J. S.-A., Real, F. X., Capellá, G., Estanyol, J. M., Jaumot, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.041 · Cited by 65
A PML/Slit Axis Controls Physiological Cell Migration and Cancer Invasion in the CNS
Amodeo, V., Deli, A., Betts, J., Bartesaghi, S., Zhang, Y., Richard-Loendt, A., Ellis, M. J., Roshani, R., Vouri, M., Galavotti, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.047 · Cited by 68
Pergolini, I., Morales‐Oyarvide, V., Mino-Kenudson, M. A., Honselmann, K. C., Rosenbaum, M. W., Nahar, S., Kem, M., Ferrone, C. R., Lillemoe, K. D., Bardeesy, N. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182855 · Cited by 65
Takahashi, D., Kojima, M., Suzuki, T., Sugimoto, M., Kobayashi, S., Takahashi, S., Konishi, M., Gotohda, N., Ikeda, M., Nakatsura, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31383-9 · Cited by 63
Kalluri, V. S., Smaglo, B. G., Mahadevan, K. K., Kirtley, M. L., McAndrews, K. M., Mendt, M., Yang, S., Maldonado, A. S., Sugimoto, H., Salvatierra, M. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63718-2 · Cited by 70
Self-citationWu, H., Wang, Q., Zhong, H., Li, L., Zhang, Q., Huang, Q., & Yu, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7401 · Cited by 62
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
Mastrantonio, R., You, H., & Tamagnone, L. (2021) · Theranostics · doi:10.7150/thno.54023 · Cited by 62
Cheruiyot, A., Li, S., Srivatsan, S. N., Ahmed, T., Chen, Y., Lemacon, D. S., Li, Y., Yang, Z., Wadugu, B. A., Warner, W. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4016 · Cited by 61
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer
Zhang, X., Mao, T., Zhang, B., Xu, H., Cui, J., Jiao, F., Chen, D., Wang, Y., Hu, J., Xia, Q., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103897 · Cited by 62
Chang, D. K.-F., Grimmond, S. M., & Biankin, A. V. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.001 · Cited by 62
Self-citationModeling Targeted Inhibition of MEK and PI3 Kinase in Human Pancreatic Cancer
Junttila, M. R., Devasthali, V., Cheng, J. H., Castillo, J., Metcalfe, C., Clermont, A. C., Otter, D. D., Chan, E., Bou-Reslan, H., Cao, T. C., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0030 · Cited by 61
Macchini, M., Chiaravalli, M., Zanon, S. M., Peretti, U., Mazza, E. A., Gianni, L., & Reni, M. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.10.013 · Cited by 63
Liquid biopsies for management of pancreatic cancer
Samandari, M., Juliá, M. G., Rice, A. J., Chronopoulos, A., & Hernández, A. E. D. R. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.008 · Cited by 66
Beglyarova, N., Banina, E., Zhou, Y., Mukhamadeeva, R., Andrianov, G. V., Bobrov, E., Lysenko, E., Skobeleva, N., Gabitova, L., Restifo, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0149 · Cited by 62
Hu, L., Liang, S., Chen, H., Lv, T., Wu, J., Chen, D., Wu, M. C., Sun, S., Zhang, H., You, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617816114 · Cited by 62
Self-citationRecurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
Feigin, M. E., Garvin, T. H., Bailey, P. J., Waddell, N., Chang, D. K.-F., Kelley, D. R., Shuai, S., Gallinger, S., McPherson, J. D., Grimmond, S. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3861 · Cited by 64
Self-citationThe activating transcription factor 2: an influencer of cancer progression
Huebner, K., Procházka, J., Monteiro, A. C., Mahadevan, V., & Schneider‐Stock, R. (2019) · Mutagenesis · doi:10.1093/mutage/gez041 · Cited by 61
Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1
Kishikawa, T., Otsuka, M., Yoshikawa, T., Ohno, M., Ijichi, H., & Koike, K. (2016) · Nature Communications · doi:10.1038/ncomms13006 · Cited by 45
Shibayama, Y., Fujimori, T., Nguyen, G., Hirose, T., Totsune, K., Ichihara, A., Kitada, K., Nakano, D., Kobori, H., Kohno, M., et al. (2015) · Scientific Reports · doi:10.1038/srep08854 · Cited by 60
Hao, F., Xu, Q., Wang, J., Yu, S., Chang, H.-H., Sinnett-Smith, J., Eibl, G., & Rozengurt, E. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216603 · Cited by 55
Self-citationPark, J.-K., Lee, J. H., Noh, D. H., Park, J. K., Lee, K. T., Lee, J. K., Lee, K. H., Jang, K., & Cho, J. (2019) · Gut and Liver · doi:10.5009/gnl19011 · Cited by 59
Lenkiewicz, E., Malasi, S., Hogenson, T. L., Flores, L. F., Barham, W. J., Phillips, W. J., Roesler, A. S., Chambers, K. R., Rajbhandari, N., Hayashi, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0078 · Cited by 60
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Espona‐Fiedler, M., Patthey, C., Lindblad, S., Sarró, I., & Öhlund, D. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116492 · Cited by 62
Genetics of Opisthorchis viverrini-related cholangiocarcinoma
Jusakul, A., Kongpetch, S., & Teh, B. T. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000162 · Cited by 59
Somerville, T. D. D., Xu, Y., Wu, X., Maia-Silva, D., Hur, S. K., de Almeida, L. M. N., Preall, J. B., Koo, P. K., & Vakoc, C. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921484117 · Cited by 60
The roles of FOXM1 in pancreatic stem cells and carcinogenesis
Quan, M., Wang, P., Cui, J., Gao, Y., & Xie, K. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-159 · Cited by 58
Maity, G., Haque, I., Ghosh, A., Dhar, G., Gupta, V. G., Sarkar, S., Azeem, I., McGregor, D. H., Choudhary, A., Campbell, D. R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000333 · Cited by 59
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Regel, I., Mayerle, J. V., & Mukund, M. U. (2020) · Cancers · doi:10.3390/cancers12041024 · Cited by 61
Curia, M. C., Fantini, F., Lattanzio, R., Tavano, F., Mola, F. D., Piantelli, M., Battista, P., Sebastiano, P. D., & Cama, A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5616-2 · Cited by 57
Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs
Kokkinos, J., Ignacio, R. M. C., Sharbeen, G., Boyer, C. A., Gonzales‐Aloy, E., Goldstein, D., Initiative, A. P. C. G., McCarroll, J. A., & Phillips, P. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119742 · Cited by 57
Self-citationIon channel gene expression predicts survival in glioma patients
Wang, R., Gurguis, C. I., Gu, W., Ko, E., Lim, I., Bang, H., Zhou, T., & Ko, J. (2015) · Scientific Reports · doi:10.1038/srep11593 · Cited by 58
Familial and sporadic pancreatic cancer share the same molecular pathogenesis
Norris, A. L., Roberts, N. J., Jones, S., Wheelan, S. J., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., Hruban, R. H., Klein, A. P., & Eshleman, J. R. (2014) · Familial Cancer · doi:10.1007/s10689-014-9755-y · Cited by 57
Self-citationAlors‐Pérez, E., Blázquez‐Encinas, R., Alcalá, S., Viyuela-García, C., Pedraza‐Arévalo, S., Herrero‐Aguayo, V., Jiménez‐Vacas, J. M., Mafficini, A., Sánchez‐Frías, M., Cano, M. T., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02153-9 · Cited by 56
Self-citationSelective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer
Witkiewicz, A. K., Borja, N. A., Franco, J., Brody, J. R., Yeo, C. J., Mansour, J., Choti, M. A., McCue, P., & Knudsen, E. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3819 · Cited by 56
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Birnbaum, D. J., Finetti, P., Lopresti, A., Gilabert, M., Poizat, F., Raoul, J.-L., Delpero, J.-R., Moutardier, V., Birnbaum, D., Mamessier, E., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0936-z · Cited by 51
Pajic, M., Herrmann, D., Vennin, C., Conway, J. R. W., Chin, V. T., Johnsson, A., Welch, H. C. E., & Timpson, P. (2015) · Small GTPases · doi:10.4161/21541248.2014.973749 · Cited by 57
Self-citationMolecular pathology of pancreatic cancer
Saiki, Y., & Horii, A. (2014) · Pathology International · doi:10.1111/pin.12114 · Cited by 58
Loerch, S., Maucuer, A., Manceau, V., Green, M. R., & Kielkopf, C. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.558825 · Cited by 58
Craven, K. E., Gore, J., & Korc, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.047 · Cited by 59
Campa, D., Pastore, M., Gentiluomo, M., Talar‐Wojnarowska, R., Kupčinskas, J., Malecka-Panas, E. I., Neoptolemos, J. P., Niesen, W., Vodička, P., Fave, G. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10935 · Cited by 55
Self-citationEvaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis
Uesato, Y., Sasahira, N., Ozaka, M., Sasaki, T., Takatsuki, M., & Zembutsu, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235623 · Cited by 56
PGTools: A Software Suite for Proteogenomic Data Analysis and Visualization
Nagaraj, S. H., Waddell, N., Madugundu, A. K., Wood, S., Jones, A., Mandyam, R. A., Nones, K., Pearson, J. V., & Grimmond, S. M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00029 · Cited by 55
Self-citationFan, X., Lü, P., Wang, H., Bian, S., Wu, X., Zhang, Y., Liu, Y., Fu, D., Wen, L., Hao, J., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00366-y · Cited by 54
ROBO3 promotes growth and metastasis of pancreatic carcinoma
Han, S., Cao, C., Tang, T., Lu, C., Xu, J., Wang, S., Xue, L., Zhang, X., & Li, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.004 · Cited by 55
Fujikura, K., Akita, M., Ajiki, T., Fukumoto, T., Itoh, T., & Zen, Y. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001155 · Cited by 55
Gendoo, D. M. A., Denroche, R. E., Zhang, A. X. W., Radulovich, N., Jang, G. H., Lemire, M., Fischer, S. E., Chadwick, D. E., Lungu, I. M., Ibrahimov, E., et al. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006596 · Cited by 57
Self-citationCT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma
Attiyeh, M. A., Chakraborty, J., McIntyre, C. A., Kappagantula, R. L., Chou, Y., Aşkan, G., Seier, K., Gönen, M., Baştürk, O., Balachandran, V. P., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02112-1 · Cited by 56
Self-citationSystematic tracking of dysregulated modules identifies novel genes in cancer
Srihari, S., & Ragan, M. A. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt191 · Cited by 77
Levin, N., Paria, B. C., Vale, N. R., Yossef, R., Lowery, F. J., Parkhurst, M. R., Yu, Z., Florentin, M., Cafri, G., Gartner, J. J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0849 · Cited by 54
Hyeon, D. Y., Nam, D., Han, Y., Kim, D. K., Kim, G., Kim, D., Bae, J., Back, S., Mun, D., Madar, I. H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00479-7 · Cited by 57
Self-citationTranscriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A
Hoskins, J. W., Jia, J., Flández, M., Parikh, H. M., Xiao, W., Collins, I. J., Emmanuel, M. A., Ibrahim, A. M., Powell, J. I., Zhang, L., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu193 · Cited by 54
Self-citationValero, V., Saunders, T., He, J. P., Weiss, M. J., Cameron, J. L., Dholakia, A. S., Wild, A. T., Shin, E. J., Khashab, M. A., Lennon, A. M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001156 · Cited by 55
Self-citationGenomic signatures of pancreatic adenosquamous carcinoma (PASC)
Fang, Y., Su, Z., Xie, J., Xue, R., Ma, Q., Li, Y., Zhao, Y., Song, Z., Lu, X., Li, H., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4943 · Cited by 54
Chandrasegaram, M. D., Gill, A. J., Samra, J., Price, T., Chen, J. L., Fawcett, J., & Merrett, N. D. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i10.407 · Cited by 54
Self-citationSelective targeting of KRAS oncogenic alleles by CRISPR/Cas9 inhibits proliferation of cancer cells
Lee, W., Lee, J. H., Jun, S., Lee, J. H., & Bang, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-30205-2 · Cited by 53
Gendoo, D. M. A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.01.010 · Cited by 53
Choudhury, A., Hazelhurst, S., Meintjes, A., Oduaran, O. H., Aron, S., Gamieldien, J., Dashti, M. J. S., Mulder, N., Tiffin, N., & Ramsay, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-437 · Cited by 62
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
Adamo, P., Cowley, C. M., Neal, C. P., Mistry, V., Page, K., Dennison, A. R., Isherwood, J., Hastings, R. K., Luo, J., Moore, D. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20250 · Cited by 54
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
Self-citationA genetic roadmap of pancreatic cancer: still evolving
Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 56
Lakis, V., Lawlor, R. T., Newell, F., Patch, A., Mafficini, A., Sadanandam, A., Koufariotis, L. T., Johnston, R. L., Leonard, C., Wood, S., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01469-0 · Cited by 53
Self-citationDHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
Zhang, J., Huang, J. W., Xu, K., Xing, P., Huang, Y., Liu, Z., Tong, L., & Manley, J. L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216712119 · Cited by 53
Hsu, P.-Y., Hsu, H.-K., Lan, X., Juan, L., Yan, P. S., Labanowska, J. M., Heerema, N. A., Hsiao, T., Chiu, Y., Chen, Y., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.007 · Cited by 53
Şahin, İ. H., Lowery, M. A., Stadler, Z. K., Salo‐Mullen, E. E., Iacobuzio–Donahue, C. A., Kelsen, D. P., & O'Reilly, E. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1153424 · Cited by 56
Self-citationIntSIM: An Integrated Simulator of Next-Generation Sequencing Data
Yuan, X., Zhang, J., & Yang, L. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2560939 · Cited by 52
Sivakumar, S., de Santiago, I., Chlon, L., & Markowetz, F. M. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002223 · Cited by 51
ISOWN: accurate somatic mutation identification in the absence of normal tissue controls
Kalatskaya, I., Trinh, Q. M., Spears, M., McPherson, J. D., Bartlett, J. M. S., & Stein, L. D. (2017) · Genome Medicine · doi:10.1186/s13073-017-0446-9 · Cited by 48
Self-citationExtracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer
Veenstra, V. L., García-Garijo, A., van Laarhoven, H. W. M., & Bijlsma, M. F. (2018) · Cancers · doi:10.3390/cancers10020034 · Cited by 54
Takeuchi, S., Doi, M., Ikari, N., Yamamoto, M., & Furukawa, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-26526-x · Cited by 50
YAP in pancreatic cancer: oncogenic role and therapeutic strategy
Mao, W., Mai, J., Peng, H., Wan, J., & Sun, T. (2020) · Theranostics · doi:10.7150/thno.53438 · Cited by 54
Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions
Jun, S., Son, D., Kim, M., Kim, S. J., An, S., Park, Y. S., Park, S. R., Choi, K. D., Jung, H., Kim, S. C., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000850 · Cited by 51
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Tong, Y., Sun, M., Chen, L., Wang, Y., Yan, L., Li, L., Zhang, X., Cai, Y., Qie, J., Pang, Y., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01384-3 · Cited by 52
Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Sheikh, K., Amjad, M., Irfan, M., Anjum, S., Majeed, T., Riaz, M. U., Jassim, A. Y., Sharif, E., & Ibrahim, W. N. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s493643 · Cited by 61
Maron, R., Schechter, B., Mancini, M., Mahlknecht, G., Yarden, Y., & Sela, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313857110 · Cited by 50
Gal, M., Magen, D., Zahran, Y., Ravid, S., Eran, A., Khayat, M., Gafni, C., Levanon, E. Y., & Mandel, H. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.02.007 · Cited by 51
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Tong, Z., Hou, S., Bateman, S., Pierce, D. W., Heise, C. C., Hoff, D. D. V., Maitra, A., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.215 · Cited by 51
Self-citationAmpulla of Vater carcinoma: Molecular landscape and clinical implications
Pea, A., Riva, G., Bernasconi, R., Sereni, E., Lawlor, R. T., Scarpa, A., & Luchini, C. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i11.370 · Cited by 51
Self-citationGenomics of adult and pediatric solid tumors.
Rahal, Z., Abdulhai, F., Kadara, H. N., & Saab, R. H. (2018) · Europe PMC (PubMed Central) · Cited by 52
Murphy, K. J., Reed, D. A., Vennin, C., Conway, J. R. W., Nobis, M., Yin, J. X. M., Chambers, C. R., Pereira, B., Lee, V., Filipe, E. C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh0363 · Cited by 54
Self-citationUnderstanding next generation sequencing in oncology: A guide for oncologists
Moorcraft, S. Y., de Castro, D. G., & Walker, B. A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.06.007 · Cited by 51
Molecular Subtyping and Precision Medicine for Pancreatic Cancer
Froeling, F. E. M., Casolino, R., Pea, A., Biankin, A. V., Chang, D. K.-F., & Precision-Panc, O. B. O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10010149 · Cited by 52
Self-citationTraub, B., Link, K. H., & Kornmann, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.030 · Cited by 51
Frontzek, F., Staiger, A. M., Zapukhlyak, M., Xu, W., Bonzheim, I., Borgmann, V., Sander, P., Baptista, M. J., Heming, J.-N., Berning, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25405-w · Cited by 51
Identification of FoxR2 as an Oncogene in Medulloblastoma
Koso, H., Tsuhako, A., Lyons, E., Ward, J. M., Rust, A. G., Adams, D. J., Jenkins, N. A., Copeland, N. G., & Watanabe, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1523 · Cited by 52
Self-citationKüsters‐Vandevelde, H. V. N., Creytens, D., Grunsven, A. C. H. V. E., Jeunink, M. A. F., Winnepenninckx, V. J. L., Groenen, P. J. T. A., Küsters, B., Wesseling, P., Blokx, W. A. M., & Prinsen, C. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0272-0 · Cited by 50
Mathew, E., Collins, M. A., Fernández‐Barrena, M. G., Holtz, A. M., Yan, W., Hogan, J. O., Tata, Z., Allen, B. L., Fernández-Zapico, M. E., & di Magliano, M. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556563 · Cited by 52
Huang, Y., Nahar, S., Nakagawa, A., Fernández‐Barrena, M. G., Mertz, J. A., Bryant, B. M., Adams, C. E., Mino-Kenudson, M. A., Alt, K. N. V., Chang, K. K., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2068 · Cited by 50
Self-citationCirculating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
Takai, E., & Yachida, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i38.8480 · Cited by 53
Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
Zhang, J., Wolfgang, C. L., & Zheng, L. (2018) · Cancers · doi:10.3390/cancers10020039 · Cited by 52
Self-citationXia, Y., Wang, L., Xu, Z., Kong, R., Wang, F., Yin, K., Xu, J., Li, B., He, Z., Wang, L., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12606 · Cited by 50
Self-citationPancreas–Microbiota Cross Talk in Health and Disease
Adolph, T. E., Mayr, L., Grabherr, F., Schwärzler, J., & Tilg, H. (2019) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082018-124306 · Cited by 48
Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway
Yang, Y., Huynh, N. T., Dumesny, C., Wang, K., He, H. Z., & Nikfarjam, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218035 · Cited by 50
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
Linehan, A., O’Reilly, M., McDermott, R., & O'Kane, G. M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1369136 · Cited by 57
The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression
Schaal, C. M., Padmanabhan, J., & Chellappan, S. (2015) · Cancers · doi:10.3390/cancers7030845 · Cited by 49
Metadata
- Authors
- Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., Wu, J., Chang, D. K., Cowley, M. J., Gardiner, B. B., Song, S., Harliwong, I., Idrisoglu, S., Nourse, C., Nourbakhsh, E., Manning, S., Wani, S., Gongora, M., Pajic, M., Scarlett, C. J., Gill, A. J., Pinho, A. V., Rooman, I., Anderson, M., Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Nones, K., Lynn Fink, J., Christ, A., Bruxner, T., Cloonan, N., Kolle, G., Newell, F., Pinese, M., Scott Mead, R., Humphris, J. L., Kaplan, W., Jones, M. D., Colvin, E. K., Nagrial, A. M., Humphrey, E. S., Chou, A., Chin, V. T., Chantrill, L. A., Mawson, A., Samra, J. S., Kench, J. G., Lovell, J. A., Daly, R. J., Merrett, N. D., Toon, C., Epari, K., Nguyen, N. Q., Barbour, A., Zeps, N., Kakkar, N., Zhao, F., Qing Wu, Y., Wang, M., Muzny, D. M., Fisher, W. E., Charles Brunicardi, F., Hodges, S. E., Reid, J. G., Drummond, J., Chang, K., Han, Y., Lewis, L. R., Dinh, H., Buhay, C. J., Beck, T., Timms, L., Sam, M., Begley, K., Brown, A., Pai, D., Panchal, A., Buchner, N., De Borja, R., Denroche, R. E., Yung, C. K., Serra, S., Onetto, N., Mukhopadhyay, D., Tsao, M.-S., Shaw, P. A., Petersen, G. M., Gallinger, S., Hruban, R. H., Maitra, A., Iacobuzio-Donahue, C. A., Schulick, R. D., Wolfgang, C. L., Morgan, R. A., Lawlor, R. T., Capelli, P., Corbo, V., Scardoni, M., Tortora, G., Tempero, M. A., Mann, K. M., Jenkins, N. A., Perez-Mancera, P. A., Adams, D. J., Largaespada, D. A., Wessels, L. F. A., Rust, A. G., Stein, L. D., Tuveson, D. A., Copeland, N. G., Musgrove, E. A., Scarpa, A., Eshleman, J. R., Hudson, T. J., Sutherland, R. L., Wheeler, D. A., Pearson, J. V., McPherson, J. D., Gibbs, R. A., & Grimmond, S. M.
- Affiliations
- Garvan Institute of Medical Research (AU)
- The University of Queensland (AU)
- Ontario Institute for Cancer Research (CA)
- The University of Sydney (AU)
- Royal Adelaide Hospital (AU)
- St John of God Subiaco Hospital (AU)
- Baylor College of Medicine (US)
- University of California, Los Angeles (US)
- University Health Network (CA)
- Johns Hopkins University (US)
- University of Verona (IT)
- Houston Methodist (US)
- University of Minnesota (US)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Grimmond, Sean M.
- ORCID
- Biankin, Andrew V.
- Waddell, Nicola
- Kassahn, Karin S.
- Gingras, Marie-Claude
- Muthuswamy, Lakshmi B.
- Johns, Amber L.
- Wilson, Peter J.
- Patch, Ann-Marie
- Wu, Jianmin
- Chang, David K.
- Cowley, Mark J.
- Gardiner, Brooke B.
- Song, Sarah
- Harliwong, Ivon
- Nourbakhsh, Ehsan
- Manning, Suzanne
- Wani, Shivangi
- Pajic, Marina
- Scarlett, Christopher J.
- Gill, Anthony J.
- Pinho, Andreia V.
- Rooman, Ilse
- Anderson, Matthew
- Holmes, Oliver
- Leonard, Conrad
- Wood, Scott
- Christ, Angelika
- Cloonan, Nicole
- Newell, Felicity
- Pinese, Mark
- Kaplan, Warren
- Jones, Marc D.
- Colvin, Emily K.
- Nagrial, Adnan M.
- Chou, Angela
- Chin, Venessa T.
- Chantrill, Lorraine A.
- Mawson, Amanda
- Samra, Jaswinder S.
- Kench, James G.
- Daly, Roger J.
- Merrett, Neil D.
- Toon, Christopher
- Nguyen, Nam Q.
- Barbour, Andrew
- Zeps, Nikolajs
- Zhao, Fengmei
- Muzny, Donna M.
- Drummond, Jennifer
- Chang, Kyle
- Han, Yi
- Dinh, Huyen
- Beck, Timothy
- Begley, Kimberly
- Brown, Andrew
- Denroche, Robert E.
- Yung, Christina K.
- Serra, Stefano
- Mukhopadhyay, Debabrata
- Tsao, Ming-Sound
- Petersen, Gloria M.
- Hruban, Ralph H.
- Maitra, Anirban
- Schulick, Richard D.
- Wolfgang, Christopher L.
- Lawlor, Rita T.
- Corbo, Vincenzo
- Tortora, Giampaolo
- Tempero, Margaret A.
- Mann, Karen M.
- Jenkins, Nancy A.
- Adams, David J.
- Wessels, Lodewyk F. A.
- Rust, Alistair G.
- Stein, Lincoln D.
- Tuveson, David A.
- Scarpa, Aldo
- Eshleman, James R.
- Hudson, Thomas J.
- Wheeler, David A.
- Pearson, John V.
- McPherson, John D.
- Gibbs, Richard A.
- Grimmond, Sean M.
- Venue
- Nature
- Published
- 2012-10-24
- Volume
- 491
- Issue
- 7424
- Pages
- 399-405
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3530898
- OpenAlex
- W2161884651
- Cited by
- 2,058
- References
- 41
- Citations by year
- 2026: 62 · 2025: 98 · 2024: 90 · 2023: 128 · 2022: 173 · 2021: 190 · 2020: 168 · 2019: 163 · 2018: 159 · 2017: 187 · 2016: 191 · 2015: 176 · 2014: 157 · 2013: 113 · 2012: 1
- FWCI
- 70.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- American Association for Cancer Research
- Cancer Prevention and Research Institute of Texas (RP101353-P7, RP101353)
- Johns Hopkins University (P50CA062924)
- Royal College of Pathologists of Australasia
- Wellcome Trust
- Australian Government
- Cancer Research UK (13031)
- Australian Cancer Research Foundation
- Cancer Institute NSW
- Gastroenterological Society of Australia
- Royal Australasian College of Physicians
- Agency for Science, Technology and Research
- Petre Foundation
- Queensland Government
- R.T. Hall Trust
- Associazione Italiana per la Ricerca sul Cancro (12182, 5 x mille)
- Università degli Studi di Verona
- Ministero dello Sviluppo Economico
- National Institutes of Health (CA102701)
- Medical Research Council
- National Health and Medical Research Council (535914, 631701, 535903, 427601)
- Cancer Council NSW (SRP06-01)
- National Human Genome Research Institute (HG003273, U54HG003273)
- National Cancer Institute (CA102701, R01CA-97075, P01CA134292, P50CA101955, P50CA102701, R01CA113636, R01CA097075, P50CA062924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic ductal adenocarcinoma, axon guidance genes, somatic mutations, copy number variation, chromatin modification, DNA repair, ATM, carcinogenesis, pathway analysis, patient survival, Sleeping Beauty transposon mutagenesis, early-stage pancreatic cancer
- MeSH terms
- Animals, Axons, Humans, Mutation, Pancreatic Neoplasms, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Gene Dosage, Carcinoma, Pancreatic Ductal, Mice, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
